Skip to content

Effect of Self-administered Auricular Acupressure on Smoking Cessation-a Pilot Study

Effect of Self-administered Auricular Acupressure on Smoking Cessation-a Pilot Study

Status
UNKNOWN
Phases
Phase 2
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01389622
Enrollment
60
Registered
2011-07-08
Start date
2011-07-31
Completion date
2016-01-31
Last updated
2014-11-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Smoking Cessation

Keywords

Acupuncture, smoking cessation

Brief summary

Auricular acupressure has been practiced in China and Germany to help people in smoking cessation programs. The purpose of this clinical trial is to test for the clinical effectiveness of self-administered auricular acupressure as a non-invasive method for smoking cessation.

Detailed description

Auricular acupressure has been practiced in China and Germany to help people in smoking cessation programs with varying degrees of success in different settings. The purpose of this clinical trial is to test for the clinical effectiveness of self-administered auricular acupressure as a non-invasive method for smoking cessation.

Interventions

OTHERacupuncture

National Acupuncture Detoxification Association (NADA) points + digital pressure

Sponsors

Queen's University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 75 Years
Healthy volunteers
Yes

Inclusion criteria

* Participants are included in the study if they satisfy the following criteria: * Male or female. * Between 18 and 75 years of age inclusive. * Able to provide informed consent to study. * History of tobacco cigarette smoking for at least 6 months. * Confirmed intention of smoking cessation with no more than 2 previous failed attempts in the last 3 year.

Exclusion criteria

* Existing pharmacotherapy for smoking cessation. * History of major psychiatric disorder or chronic pain syndromes. * More than 2 failed attempts of smoking cessation in the previous 3 years. * History of other substance abuse. * History of atopy, or suspected/known allergy to plaster.

Design outcomes

Primary

MeasureTime frameDescription
Spot 7-day cessation rateWeekly during the intervention period (weeks 1-6)Efficacy of intervention for smoking cessation

Secondary

MeasureTime frameDescription
Continuous Cessation Rate (CAR)Weekly during the intervention period (weeks 1-6) and week 13 and week 26Efficacy of intervention for smoking cessation
End-expiratory carbon monoxide levels (CO)Weekly during the intervention period (weeks 1-6) and week 13 and week 26Efficacy of intervention for smoking cessation
Adverse effects in terms of self-reported discomfort levels from auricular acupressureWeekly during the intervention period (weeks 1-6)Nature and incidence of adverse events due to intervention
Stress level according to the Stress Check List (SCL)Weekly during the intervention period (weeks 1-6) and week 13 and week 26Nature and incidence of adverse events due to intervention
Nicotine withdrawal symptoms according to Minnesota Nicotine Withdrawal Scale (MNWS)Weekly during the intervention period (weeks 1-6) and week 13 and week 26Nature and incidence of adverse events due to intervention

Countries

Canada

Contacts

Primary ContactLawrence Leung, MD
lawrence.leung@dfm.queensu.ca613-533-9303
Backup ContactJyoti Kotecha, MPA
jyoti.kotecha@cspc.queensu.ca613-533-6000

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 27, 2026